520 related articles for article (PubMed ID: 16125826)
1. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.
Metlay JP; Fishman NO; Joffe M; Edelstein PH
Vaccine; 2006 Jan; 24(4):468-75. PubMed ID: 16125826
[TBL] [Abstract][Full Text] [Related]
2. [Bacteremic pneumococcal pneumonia].
Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
[TBL] [Abstract][Full Text] [Related]
3. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
5. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
[TBL] [Abstract][Full Text] [Related]
7. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
Adam D; Fehnle K
Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
[TBL] [Abstract][Full Text] [Related]
10. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
12. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
[TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
[TBL] [Abstract][Full Text] [Related]
15. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings.
Givon-Lavi N; Fraser D; Dagan R
Pediatr Infect Dis J; 2003 Jun; 22(6):524-32. PubMed ID: 12799509
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
[TBL] [Abstract][Full Text] [Related]
18. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
[TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
Scheifele D; Halperin S; Pelletier L; Talbot J
Clin Infect Dis; 2000 Jul; 31(1):58-64. PubMed ID: 10913397
[TBL] [Abstract][Full Text] [Related]
20. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
